Pages that link to "Q33182358"
Jump to navigation
Jump to search
The following pages link to Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women (Q33182358):
Displaying 50 items.
- Could human papillomaviruses be spread through blood? (Q24538854) (← links)
- Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil (Q28385325) (← links)
- HPV clearance and the neglected role of stochasticity (Q28652424) (← links)
- HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. (Q30815896) (← links)
- The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa (Q33290996) (← links)
- Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful (Q33574329) (← links)
- Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa (Q33619797) (← links)
- The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents (Q33718690) (← links)
- Prevalence and predictors of high-risk human papillomavirus infection in a population-based sample of women in rural Uganda (Q33760807) (← links)
- Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia (Q33794306) (← links)
- Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda (Q33863369) (← links)
- Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis (Q33883532) (← links)
- Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women (Q33925189) (← links)
- The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda. (Q34089666) (← links)
- Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females (Q34146342) (← links)
- Factors affecting transmission of mucosal human papillomavirus (Q34149651) (← links)
- Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature (Q34173407) (← links)
- Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the (Q34212799) (← links)
- High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men. (Q34231736) (← links)
- Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. (Q34354553) (← links)
- HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study. (Q34448633) (← links)
- Incidence, clearance and predictors of human papillomavirus infection in women. (Q34536772) (← links)
- Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda (Q34576482) (← links)
- Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women (Q34601418) (← links)
- Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe (Q34743282) (← links)
- Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women (Q34764388) (← links)
- Cervical cancer risk factors among HIV-infected Nigerian women (Q34773250) (← links)
- Current treatment options for management of anal intraepithelial neoplasia (Q34780148) (← links)
- Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults (Q34882577) (← links)
- Oral Sex and HPV: Population Based Indications (Q34983370) (← links)
- Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated (Q35026841) (← links)
- Discrete-time semi-Markov modeling of human papillomavirus persistence (Q35085871) (← links)
- Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda (Q35172338) (← links)
- Cervical neoplasia and the HIV-infected patient. (Q35174169) (← links)
- High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study (Q35186321) (← links)
- Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection (Q35252587) (← links)
- The role of co-infections in mother-to-child transmission of HIV. (Q35542406) (← links)
- Cervical cancer screening and treatment of cervical intraepithelial neoplasia in female sex workers using "screen and treat" approach. (Q35592340) (← links)
- HPV Infection in a Cohort of HIV-Positive Men and Women: Prevalence of Oncogenic Genotypes and Predictors of Mucosal Damage at Genital and Oral Sites (Q35623688) (← links)
- Gynecologic issues in the HIV-infected woman (Q35627563) (← links)
- Comparison of Abnormal Cervical Cytology from HIV Positive Women, Female Sex Workers and General Population (Q35636647) (← links)
- CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women. (Q35694739) (← links)
- Prevalence and incidence of cervical intra-epithelial neoplasia among female sex workers in Korogocho, Kenya. (Q35719648) (← links)
- Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults (Q35758895) (← links)
- Evaluation of Cervical Cancer Screening Programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV Status (Q35787542) (← links)
- Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence (Q35865134) (← links)
- Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa (Q36319807) (← links)
- The epidemiology of genital human papillomavirus infection (Q36365671) (← links)
- Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy (Q36405118) (← links)
- Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial (Q36421345) (← links)